science
plus
.abes.fr
|
explorer
À propos de :
Lessons from the withdrawal of rofecoxib
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
bibo:Article
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
work
Article
New Facet based on Instances of this Class
Attributs
Valeurs
type
work
Article
Is Part Of
http://hub.abes.fr/bmj/periodical/bmj/2004/volume_329/issue_7471/w
Subject
Drugs: cardiovascular system
Musculoskeletal syndromes
Occupational and environmental medicine
Editorials
Connective tissue disease
Pain (anaesthesia)
Ischaemic heart disease
Pain (palliative care)
Biological agents
Pain (neurology)
Rheumatoid arthritis
Degenerative joint disease
Drugs: musculoskeletal and joint diseases
Liver disease
Clinical trials (epidemiology)
Immunology (including allergy)
Poisoning
Title
Lessons from the withdrawal of rofecoxib
has manifestation of work
http://hub.abes.fr/bmj/periodical/bmj/2004/volume_329/issue_7471/B36DBB0063D9649BE053120B220A93E8/m/print
http://hub.abes.fr/bmj/periodical/bmj/2004/volume_329/issue_7471/B36DBB0063D9649BE053120B220A93E8/m/web
related by
http://hub.abes.fr/bmj/periodical/bmj/2004/volume_329/issue_7471/B36DBB0063D9649BE053120B220A93E8/authorship/3
http://hub.abes.fr/bmj/periodical/bmj/2004/volume_329/issue_7471/B36DBB0063D9649BE053120B220A93E8/authorship/4
http://hub.abes.fr/bmj/periodical/bmj/2004/volume_329/issue_7471/B36DBB0063D9649BE053120B220A93E8/authorship/1
http://hub.abes.fr/bmj/periodical/bmj/2004/volume_329/issue_7471/B36DBB0063D9649BE053120B220A93E8/authorship/2
Abstract
Patients would be safer if drug companies disclosed adverse events before licensing
article type
editorial
publisher identifier
bmj.329.7471.867
is part of this journal
British Medical Journal
PubMed ID
15485938
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
